Tag Archives: Davos

Your Daily Dose of Financial News

BY: Michael D. Reif | January 24, 2019

Renault has wrapped discussions with Carlos Ghosn’s lawyers over whether the imprisoned former CEO and chair will resign [he will] or be removed from those positions at the company that has, unlike Nissan and Mitsubishi, thus far largely stood with him despite the fallout from his arrest in Japan some months ago – NYTimes and … Continue reading

Your Daily Dose of Financial News

BY: Michael D. Reif | January 22, 2019

As world economic leaders (sans the U.S. government) gather in Davos this week, China’s economic cooling (coming just “when the world needs its spark”) is both a hot topic of conversation and a cause for concern – NYTimes and WSJ and Bloomberg Puerto Rico is nearing finalization of a mammoth $18 billion in bond restructuring … Continue reading

Your Daily Dose of Financial News

BY: Michael D. Reif | January 29, 2018

With Davos 2018 in the rear view mirror, some analysts are pegging the “geopolitical momentum” as China’s to claim, thanks in no small part to its expansive and ongoing “Belt and Road” initiative – NYTimes Need more proof of China’s rising status? Intel apparently warned Chinese companies like Alibaba and Lenovo of its chip flaws … Continue reading

Your Daily Dose of Financial News

BY: Michael D. Reif | January 26, 2018

ECB Chief Mario Draghi’s having none of the US Treasury Secretary’s recent weak-dollar talk, accusing the US official, in not so many words, of “violating agreements among nations against starting currency wars” – NYTimes and WSJ The Times takes us inside the rigged VW tests at the heart of the emissions cheating scandal that’s sullied … Continue reading

Your Daily Dose of Financial News

BY: Michael D. Reif | January 23, 2018

It was a Monday of dealmaking, with insurance giant AIG announcing a $5.56 billion agreement to acquire Bermuda-based Validus Holdings [WSJ and Bloomberg]; biotech biggie Celgene Corp. agreeing to buy Juno Therapeutics for roughly $9 billion in a move to expand its blood-cancer drugs [WSJ and Bloomberg]; Bacardi paying the “premium price” of $5.1 billion … Continue reading